The trials, designed to assess whether semaglutide could slow cognitive decline, showed no significant difference compared to placebo in the progression of Alzheimer’s disease over two years
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
Jaypirca is making waves in the fight against B-cell malignancies
Winlevi is authorized in EU for the treatment of acne vulgaris
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
The collaboration to develop breakthrough myeloid cell engagers (MCEs) signals a bold push into a promising new frontier in cancer therapy
SOMA Color Mind is designed to simplify and accelerate color setup directly on the printing press
The initiative aims to connect startups and tech companies with its business units,
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
